Table 3 Comparing group levels of CSF YKL-40, neopterin, and NFL using Tukey’s multiple comparison test after one-way ANOVA
Group comparisons | CSF YKL-40 (log) | CSF neopterin (log) | CSF NFL (log) |
|---|---|---|---|
Overall ANOVA p | |||
< 0.0001 | < 0.0001 | < 0.0001 | |
Tukey’s multiple comparison | |||
HAD vs. HIV– | < 0.0001 | ND | < 0.0001 |
HAD vs. ART | < 0.0001 | < 0.0001 | < 0.0001 |
HAD vs. NA CD4 ≥ 350 | < 0.0001 | < 0.0001 | < 0.0001 |
HAD vs. NA CD4 200–349 | < 0.0001 | ns | < 0.0001 |
HAD vs. NA CD4 50–199 | < 0.0001 | ns | < 0.0001 |
HAD vs. NA CD4 < 50 | < 0.0001 | ns | < 0.0001 |
NA CD4 < 50 vs. HIV– | < 0.0001 | ND | < 0.0001 |
NA CD4 < 50 vs. ART | < 0.05 | < 0.0001 | < 0.0001 |
NA CD4 < 50 vs. NA CD4 ≥ 350 | < 0.05 | < 0.0001 | < 0.0001 |
NA CD4 < 50 vs. NA CD4 200–349 | ns | ns | < 0.0001 |
NA CD4 < 50 vs. NA CD4 50–199 | ns | ns | ns |
NA CD4 50–199 vs. HIV– | < 0.0001 | ND | ns |
NA CD4 50–199 vs. ART | ns | < 0.0001 | < 0.05 |
NA CD4 50–199 vs. NA CD4 ≥ 350 | ns | < 0.01 | ns |
NA CD4 50–199 vs. NA CD4 200–349 | ns | ns | ns |
NA CD4 200–349 vs. HIV– | < 0.05 | ND | ns |
NA CD4 200–349 vs. ART | ns | < 0.0001 | ns |
NA CD4 200–349 vs. NA CD4 ≥ 350 | ns | < 0.05 | ns |
NA CD4 ≥ 350 vs. HIV– | ns | ND | ns |
NA CD4 ≥ 350 vs. ART | ns | < 0.01 | ns |
ART vs. HIV– | ns | ND | ns |